Rarer diabetes patients in Singapore can now receive up to 80% government subsidies for continuous glucose monitoring (CGM) devices, halving monthly costs. Read more at straitstimes.com. Read more at ...

DexCom Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy in 2026. On December 2, Morgan Stanley upgraded DexCom to ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

One piece of legislation that could be on the state Legislature’s agenda next year is one that would require health insurers to provide coverage for continuous blood glucose monitors for children.

Abbott (NYSE:ABT) today unveiled a new feature within its FreeStyle Libre app for continuous glucose monitoring (CGM).

Lingo is Abbott’s over-the-counter continuous glucose monitor (CGM) for nondiabetic people. Withings users will also be able ...

DexCom overview and recent share performance DexCom (DXCM) has drawn fresh attention as investors reassess its continuous glucose monitoring business and recent share performance, with the stock last ...

FDA announces wearable devices providing non-medical info won't face regulation, offering clarity on digital health ...

Kakao Healthcare said on the 12th that it signed an exclusive domestic supply contract with Dexcom, a global glucose biosensing corporations. Under the agreement, Kakao Healthcare will be responsible ...

Adults with type 1 or type 2 diabetes who used a continuous glucose monitor experienced fewer emergency department and ...

As the United States approaches 2026, key structural shifts in retirement and healthcare financing are poised to affect how ...

Once-weekly semaglutide 1 mg was tied to a reduction in total daily insulin dose among adults with type 1 diabetes, ...